Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-14,146
Closed -$784K 1761
2020
Q3
$784K Buy
+14,146
New +$734K 0.01% 867
2020
Q1
Sell
-55,546
Closed -$1.99M 2553
2019
Q4
$1.99M Buy
55,546
+46,398
+507% +$1.72M 0.02% 1058
2019
Q3
$320K Buy
+9,148
New +$352K ﹤0.01% 2146
2019
Q2
Sell
-28,292
Closed -$1.22M 2812
2019
Q1
$1.22M Buy
28,292
+9,902
+54% +$398K 0.01% 1173
2018
Q4
$672K Buy
+18,390
New +$683K 0.01% 1352

Other funds holding QGEN

Jefferies Group's QGEN Position: Q2 2022 in Review

Jefferies Group sold out of Qiagen (QGEN) in Q2 2022, closing a stake of 235,217 shares — an estimated $12.2M sold.

Jefferies Group first reported a position in QGEN in Q1 2017 and held it in 18 quarters. The position peaked at $16.9M in Q4 2018. 287 funds tracked by Wall St. Rank hold QGEN as of Q2 2022.

  • Jefferies Group reported no remaining Qiagen position as of Q2 2022 after selling out during the quarter.
  • Jefferies Group sold 235,217 Qiagen shares in Q2 2022, an estimated $12.2M.
  • Jefferies Group first reported a position in Qiagen in Q1 2017 and held it in 18 quarters.
  • Jefferies Group's Qiagen position peaked at $16.9M in Q4 2018.
  • 287 funds tracked by Wall St. Rank held Qiagen as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.